Cisatracurium besylate lcarbamazine citrate Quizartinib inhibits FLT3 with low

Quizartinib inhibits FLT3 with low nanomolar potency in cellular assays and is highly selective when screened against the majority of the human protein kinome

It inhibits the interaction between β-catenin and T cell factor 4 (Tcf4) in quantitative reporter assays of β-catenin/Tcf4 binding (Ki = 53

[O-]C(=O)C1C=C(N=C2C=CC=CC2=1)C1C=C(C2=CC=CC=C2N=1)C([O-])=O

CAS Number: 191089-60-8

Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages

Cisatracurium besylate lcarbamazine citrate Quizartinib inhibits FLT3 with lowCisatracurium (formerly recognized as 51W89, and marketed as Nimbex) is a neuromuscular blocking drug or skeletal muscle relaxant in the category of non depolarizing neuromuscular blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is a bisbenzyltetrahydroisoquinolinium agent with an intermediate duration of action. Cisatracurium is